The Annals of pharmacotherapy
Toripalimab and Penpulimab: Targeting PD-1 in Recurrent or Metastatic Nasopharyngeal Carcinoma.
Josie J Hockett, Molly E Keller, David J Reeves
Published: 202510.1177/10600280251391430
Abstract
OBJECTIVE: The objective of this review is to evaluate clinical data regarding use of toripalimab and penpulimab use in recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) and to assess their impact on patient care. DATA SOURCES: A literature s…
Preview only. Read the full abstract at the source